Value of pharmaceutical gross-to-net reduction in the U.S. 2012-2019
This statistic shows the total value of pharmaceutical manufacturers gross-to-net reductions on medications in the United States from 2012 to 2019, in billion U.S. dollars. In 2019, rebates and discounts provided by manufacturers totaled some 175 billion dollars.